Which of the following statements best describes scopolamine?

Prepare for the DAANCE Module 3 Exam with flashcards and multiple-choice questions. Each question comes with hints and explanations. Ensure your success!

Multiple Choice

Which of the following statements best describes scopolamine?

Scopolamine is best described by its more pronounced CNS depressant properties. This medication is classified as an anticholinergic and is primarily used to prevent nausea and motion sickness. Its mechanism involves blocking the action of acetylcholine in the nervous system, particularly in the vestibular system, which contributes to motion sickness, and in the brain's vomiting center. The CNS depressant effects of scopolamine can lead to sedation and drowsiness, which is why it's commonly used in settings where reducing awareness and movement is beneficial. This characteristic is significant when considering patient management, especially if scopolamine is administered preoperatively or for sedation. In regard to the other statements, while scopolamine can influence heart rate, such effects are typically variable; thus, stating it increases heart rate is not universally accurate. Additionally, scopolamine is known for having notable CNS effects rather than minimal ones. It is not effective for reversing benzodiazepines, which require specific antidotes such as flumazenil. Hence, the accurate description focuses on the pronounced CNS depressant properties of scopolamine.

Scopolamine is best described by its more pronounced CNS depressant properties. This medication is classified as an anticholinergic and is primarily used to prevent nausea and motion sickness. Its mechanism involves blocking the action of acetylcholine in the nervous system, particularly in the vestibular system, which contributes to motion sickness, and in the brain's vomiting center.

The CNS depressant effects of scopolamine can lead to sedation and drowsiness, which is why it's commonly used in settings where reducing awareness and movement is beneficial. This characteristic is significant when considering patient management, especially if scopolamine is administered preoperatively or for sedation.

In regard to the other statements, while scopolamine can influence heart rate, such effects are typically variable; thus, stating it increases heart rate is not universally accurate. Additionally, scopolamine is known for having notable CNS effects rather than minimal ones. It is not effective for reversing benzodiazepines, which require specific antidotes such as flumazenil. Hence, the accurate description focuses on the pronounced CNS depressant properties of scopolamine.

More practice questions